Global Medicines Development
GMD transforms molecules into medicines that change lives. Our medical, clinical and scientific experts generate data to get new medicines approved and evidence to show their true value.
Patients in clinical trials each year
Medicines in late-stage development (June 2015)
Publications from GMD scientists each year
Our GMD capabilities
GMD has deep disease area, scientific and medical knowledge – connecting our science to the needs of physicians, healthcare professionals and patients to help deliver better, safer, more effective medicines.
Clinical trial design
We drive smart clinical development programmes to give clear evidence and data to answer questions about our medicines. Our expertise includes large outcomes trials, where we apply our world-leading capabilities in delivering multi-country, multi-site studies involving thousands of patients to demonstrate how our medicines help reduce events like heart attacks and strokes.
Statistical modelling and analysis
We are pioneers in applying the latest computer modelling and simulation technologies to predict the potential outcomes from our large clinical studies.
Translational patient safety
We apply our scientific knowledge of human biology to provide insight into pre-clinical drug projects, helping to ensure we can apply robust safety assessments in our early clinical trials.
Global regulatory and payer expertise
We combine our deep understanding of the global regulatory environment and global payer landscape with our therapy area expertise to secure fast submissions and access to our medicines around the world. Our ability to provide data, analysis and evidence helps show the true value of our medicines and supports prescribers in their decision-making.
Pharmaceutical development, drug formulations and devices
We apply our expertise in pharmaceutical development and knowledge of emerging technology to go beyond the medicine, uncovering ways to help patients and healthcare providers achieve improved health outcomes. In addition, our innovative approach to drug formulations enables our teams to deliver products for early toxicology studies, global clinical trials and the scale-up for global manufacture.
Programme and project management
We harness our extensive project management skills to drive efficient drug programmes, working collaboratively with our development partners, contract research organisations and others to deliver clinical trials and the data required.
"AstraZeneca has a fantastic culture open to new ideas, engaged with the scientific community to push the boundary of what is possible. This is why I joined!"
A global reach
There are around 5,000 people in GMD. Our critical, core drug development expertise is at the heart of our three vibrant scientific centres in Gothenburg (Sweden), Cambridge (UK) and Gaithersburg (US). GMD scientists are located in other research locations, supporting important clinical development and pharmaceutical development activities along with clinical trial site management and monitoring in around 40 countries.
Working in partnership
To push the boundaries of science to deliver life-changing medicines we continually seek out opportunities to combine our scientific experience and insights with that of other leading institutions around the world.
Academic research organisations
Enabling us to reach the right patients quickly for clinical trials. Read about our global research collaboration with PatientsLikeMe.
Contract research organisations
Providing us access to leading clinical trial delivery expertise, supplementing our own clinical development delivery and giving us flexibility when we need it.
Enabling us to access the latest systems, tools and process know-how to help accelerate our core drug development activities.
Externally sponsored research
Our dedicated Externally Sponsored Scientific Research Operations System provides researchers with the opportunity to review compounds and areas of research interest and submit research proposals.
We partner with others around the world, combining the great science in our labs with complementary technologies, know-how and molecules to accelerate the delivery of new life-changing medicines.
Be among our employees who continue to make us an innovation-driven company that stands firmly among the world’s leaders in biopharmaceuticals.